Thyroid disorders in pregnancy

Exam relevance: in 3 of more than 150 board exam reports · rank 125

Specialty
Obstetrics · Pregnancy disorders
Images
Ultrasound 1
Exam relevance
3 of more than 150 reports · rank 125
Last updated
10/2026 · Dr. Pascal Bafteh
Contents
  1. Images (1)
  2. Definition
  3. Classification
  4. Aetiopathogenesis
  5. Clinical features
  6. Diagnosis
  7. Treatment principles
  8. Keep learning in the app
  9. Further reading (selection)
  10. Cross-references

Images (1)

Thyroid disorders in pregnancy – Prenatal ultrasound in maternal Graves' disease: fetal goitre – (a) enlarged thyroid at the fetal neck (outlined), (b) colour Doppler with peripheral vascularityUltrasound
Prenatal ultrasound in maternal Graves' disease: fetal goitre – (a) enlarged thyroid at the fetal neck (outlined), (b) colour Doppler with peripheral vascularityImage: Diawtipsukon S, Moradokkasem W, Chansriniyom N, Nuntnarumit P. (International Journal of Gynecology & Obstetrics 2025, doi:10.1002/ijgo.16060) · CC BY 4.0 · Source

Definition

  • Thyroid disorders in pregnancy comprise hypothyroidism, hyperthyroidism and thyroid autoimmunity; after diabetes, they are the most common endocrine disorders of pregnancy.

Classification

  • Transient gestational thyrotoxicosis results from direct hCG stimulation of the thyroid, usually in the first trimester, including in hyperemesis gravidarum or multiple pregnancy.

Aetiopathogenesis

Aetiology and pathogenesis

  • hCG has weak TSH receptor-stimulating activity; with the hCG peak at 10–12 weeks of gestation, TSH may be reduced in the first trimester.
  • By 6–8 weeks of gestation, thyroxine-binding globulin rises by about 50%, with a corresponding rise in total T4 and T3; iodine requirements increase.
  • The commonest cause of hypothyroidism is chronic autoimmune (Hashimoto's) thyroiditis, and the commonest cause of overt hyperthyroidism, at 85%, is Graves' disease.

Clinical features

Clinical features and complications

  • Overt hypothyroidism is associated with preterm birth, low birthweight, perinatal death, pre-eclampsia, placental abruption and anaemia.
  • TSH receptor antibodies can cross the placenta and stimulate the fetal thyroid at high concentrations; fetal hyperthyroidism is rare, at 1 in 4,000–40,000 pregnancies.

Diagnosis

  • Overt hypothyroidism is defined as TSH above the trimester-specific range with low fT4.
  • TSH receptor antibodies have high sensitivity and specificity for Graves' disease.
  • Ultrasound features suggestive of fetal thyroid dysfunction are goitre, growth restriction, hydrops, tachycardia or heart failure.

Treatment principles

  • Overt hypothyroidism is treated with thyroid hormone replacement; as requirements rise during pregnancy, the dose is adjusted based on regular blood tests.
  • Overt hyperthyroidism, usually due to Graves' disease, is treated with antithyroid drugs at the lowest effective dose, with the choice of agent depending on the trimester; radioiodine is contraindicated, and transient gestational hyperthyroidism usually needs no antithyroid treatment.
  • In Graves' disease, the fetus is monitored because of antibodies crossing the placenta; after birth, postpartum thyroiditis should be considered.

Specific treatment regimens with drugs and doses are covered in the GynFuchs app.

Keep learning in the app

In the GynFuchs app you can learn Thyroid disorders in pregnancy with flashcards, exam questions and image tasks (colposcopy, ultrasound, CTG) – free, in your browser or as an app.

Open in browser  About GynFuchs →

Further reading (selection)

  1. Benign thyroid disease in pregnancy: A state of the art review

Cross-references

Keep learning

Keep learning with flashcards, exam questions and spot diagnoses in the GynFuchs app – free, in your browser or as an app.

Related pages: Selective fetal growth restriction in twins (sFGR) · Syphilis in gynaecology and pregnancy · TAPS and TRAP sequence

Note: Learning content from the GynFuchs app (flashcards, exam questions, image cases) for medical education – not a treatment recommendation and no substitute for diagnosis or treatment decisions in individual cases. Treatment and management are deliberately not covered on this page.